A unique approach to antibody production that exposes antibody candidates to nucleosomes is revolutionizing best practices.

Identifying novel biomarkers of Parkinson’s disease enables early diagnosis and treatment monitoring.

Cancer immunotherapy targets the tumor microenvironment, blocking the molecular pathways that tumors exploit to prevent immune cell activity.

A turnkey CRO service platform for recombinant protein and antibody expression and production

Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.

Learn more about environmentally-friendly antibodies that deliver superior performance.

The Simple Western automated western blotting platform accelerates characterization of the human IgG immune response to COVID-19.